Switzerland Tests Two Ebola Vaccines

Switzerland soon to begin clinical trials of two experimental vaccines against the deadly Ebola virus, the country's Tropical and Public Health Institute said on Thursday.

"Switzerland is playing a central role in the clinical trials of two vaccines against Ebola," Marcel Tanner, who heads the Basel-based institute, told Swiss public radio SRF.

Ebola Virus Disease | Ebola Hemorrhagic Fever: Cause Symptoms Diagnosis Treatment
Ebola is caused by a virus via direct contact with body fluids or infected blood. Scientists have identified five types of Ebola or Ebola hemorrhagic fever virus.

Clinical trials should begin "as soon as possible in Geneva and Lausanne," he said.

The Swiss Agency for Therapeutic Products and an ethics commission must give the green light before the trials can begin.

Around 100 people in Switzerland are set to take part in the tests, according to SRF.

Emergency Meeting on Ebola to be Held by UN Security Council
At an emergency meeting due on Thursday, the UN Security Council will try to find ways to scale up the global response to the Ebola epidemic.

The worst Ebola outbreak on record has so far infected more than 5,350 people in Guinea, Liberia, Sierra Leone and Nigeria, killing 2,630.

There is no licensed treatment or vaccine against the virus, one of the deadliest known to man, and the World Health Organization has endorsed rushing through experimental treatments and vaccines.

Quiz on Ebola
Why is the deadly Ebola virus outbreak making the health experts hit the panic button? Find out from this quiz.

Switzerland would not be the only country hosting speedy clinical trials of potential Ebola vaccines.

Clinical trials of one such vaccine, developed by British pharmaceutical company GlaxoSmithKline, began in the United States at the beginning of the month with a handful of volunteers.

Ebola Vaccine Trial to be Done on a Healthy Briton
The first person to receive a new vaccine for the Ebola virus in a trial at the University of Oxford on Wednesday was a healthy British volunteer.

The vaccine, which has proven very effective in monkeys, has not so far shown signs of dangerous side effects. Results are due by the end of the year.

A team of researchers at Oxford in Britain are also preparing clinical trials of the same vaccine on 60 healthy volunteers.

Source-AFP